Treatment of Severe Alcoholic Hepatitis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26948886.
- Also identified by DOI 10.1053/j.gastro.2016.02.074 and PMC identifier 5828019.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alcoholic hepatitis (AH) is a syndrome of jaundice and liver failure that occurs in a minority of heavy consumers of alcohol. The diagnosis usually is based on a history of heavy alcohol use, findings from blood tests, and exclusion of other liver diseases by blood and imaging analyses. Liver biopsy specimens, usually collected via the transjugular route, should be analyzed to confirm a diagnosis of AH in patients with an atypical history or presentation. The optimal treatment for patients with severe AH is prednisolone, possibly in combination with N-acetyl cysteine. At present, only short-term increases in survival can be expected-no treatment has been found to increase patient survival beyond 3 months. Abstinence is essential for long-term survival. New treatment options, including liver transplantation, are being tested in trials and results eagerly are awaited.
Medical subject headings
- Acetylcysteine
- Free Radical Scavengers
- Glucocorticoids
- Hepatitis, Alcoholic
- Prednisolone